Skip to content

Thyroid Cancer in Surgical Treated Multinodular Goiter

Thyroid Cancer in Surgically Treated Multinodular Goiter: Incidence and Histopatological Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06924242
Enrollment
223
Registered
2025-04-11
Start date
2018-01-01
Completion date
2024-07-31
Last updated
2025-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Goiter, Nodular, Thyroid Cancer, Total Thyroidectomy

Brief summary

This study aims to investigate, based on existing knowledge, the incidence of occult thyroid carcinoma in a cohort of patients with MNG, providing new insights into the prevalence and characteristics of thyroid malignancies in MNG. It seeks to contribute to optimizing diagnostic evaluations for patients with multinodular goiter.

Detailed description

This retrospective study included patients with a preoperative diagnosis of multinodular goiter who underwent total or partial thyroidectomy from January 2018 to May 2024 at the Department of Medical and Surgical Sciences at the University Hospital Ospedali Riuniti in Foggia. The study's objective was to investigate the incidence of thyroid carcinoma in patients undergoing thyroidectomy for MNG, also analyzing associated demographic and clinical variables.

Interventions

PROCEDUREtotal or partial thyroidectomy

Total thyroidectomy is a surgical procedure that involves the complete removal of the thyroid gland. It is performed to treat conditions such as thyroid cancer, large goiters, or severe hyperthyroidism. The surgery is typically conducted under general anesthesia through an incision in the lower neck. Postoperative management may include hormone replacement therapy with levothyroxine to compensate for the loss of thyroid function. Potential complications include hypocalcemia due to parathyroid gland injury and vocal cord dysfunction from recurrent laryngeal nerve damage.

Sponsors

University of Foggia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* patients diagnosed with multinodular goiter via thyroid ultrasound, with or without FNA cytology. * patients who underwent surgery. * availability of complete clinical data

Exclusion criteria

* history of thyroid carcinoma or other thyroid neoplasms. * not completed postoperative follow up. * patients with preoperative FNA results indicating malignancy (TIR 4-5), suspicion of malignancy (TIR 3), or indeterminate significance (TIR 1)

Design outcomes

Primary

MeasureTime frameDescription
incidence of occult thyroid carcinoma6 yearsIncidence of occult thyroid carcinoma in a cohort of patients with multinodular goiter, providing new insights into the prevalence and characteristics of thyroid malignancies.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 4, 2026